Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care

Crit Care. 2020 Nov 6;24(1):639. doi: 10.1186/s13054-020-03362-y.

Sana Asif¹, Robert Frithiof¹, Miklos Lipcsey^{1

2}, Bjarne Kristensen³, Kjell Alving⁴, Michael Hultström^{5

6}

¹ Anesthesia and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University Hospital, Uppsala University, Entrance 78, etg 1, 75185, Uppsala, Sweden.
² Hedenstierna Laboratory, CIRRUS, Anesthesiology and Intensive Care, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
³ Thermo Fisher Scientific, Alleröd, Denmark.
⁴ Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
⁵ Anesthesia and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University Hospital, Uppsala University, Entrance 78, etg 1, 75185, Uppsala, Sweden. michael.hultstrom@mcb.uu.se.
⁶ Integrative Physiology, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden. michael.hultstrom@mcb.uu.se.

No abstract available

MeSH terms